Alexander Perl, MD

Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
Dr. Alexander Perl is a member of the leukemia program at the Abramson Cancer Center of the University of Pennsylvania, where he is an Associate Professor of Medicine. His particular expertise is in FLT3 inhibition as a therapeutic strategy for acute myeloid leukemia, clinical trials, and mechanisms of resistance to tyrosine kinase inhibitors.
Last modified: September 23, 2020
Authored Items

Treatment Published on October 7, 2020

Treatment Published on May 6, 2020

Treatment Published on May 6, 2020

Treatment Published on April 1, 2020

Diagnosis Published on October 10, 2018

Treatment Published on September 20, 2018